Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
ceragenix.com

See what CB Insights has to offer

Founded Year

2002

Stage

Unattributed VC | Alive

Total Raised

$3.2M

Last Raised

$3.2M | 16 yrs ago

About Ceragenix Pharmaceuticals

Ceragenix Pharmaceuticals is a Healthcare/Pharmaceuticals / Drugs company based in Denver, Colorado. Ceragenix Pharmaceuticals' investors include Viking Asset Management, Iroquois Capital and Alpha Capital Partners.

Ceragenix Pharmaceuticals Headquarter Location

1444 Wazee Street Suite 210

Denver, Colorado, 80202,

United States

720-946-6440

Latest Ceragenix Pharmaceuticals News

Ceragenix Pharmaceuticals Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Nov 27, 2016

Home » Topics » Alliances, mergers acquisitions and partnerships » Latest News » Ceragenix Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Project Synopsis: Datamonitor's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: Datamonitors' Ceragenix Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Ceragenix Pharmaceuticals, Inc. since January 2007. Scope: Provides intelligence on Ceragenix Pharmaceuticals, Inc.'s MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Ceragenix Pharmaceuticals, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for Ceragenix Pharmaceuticals, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. Highlights: This report includes Ceragenix Pharmaceuticals, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed. The profile also includes detailed deal reports for all MA, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Ceragenix Pharmaceuticals, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed. Reasons to Purchase: Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Ceragenix Pharmaceuticals, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.